Skip to main content
Erschienen in: Pediatric Nephrology 4/2020

06.12.2019 | Clinical Quiz

A rare cause of steroid-resistant nephrotic syndrome in a child: Answers

verfasst von: Lale Guliyeva, Yılmaz Tabel, Ali Düzova, Nusret Akpolat, Seza Özen, Rezan Topaloğlu, Betül Sözeri

Erschienen in: Pediatric Nephrology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

1.
What are the differential diagnoses for the case report?
 
Literatur
2.
Zurück zum Zitat Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA (2009) Management of childhood onset nephrotic syndrome. Pediatrics 124:747–757CrossRef Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA (2009) Management of childhood onset nephrotic syndrome. Pediatrics 124:747–757CrossRef
3.
Zurück zum Zitat Niaudet P, Boyer O (2016) Idiopathic nephrotic syndrome in children: clinical aspects. In: Avner ED et al (eds) Pediatric Nephrology, 7th edn. Springer-Verlag, Berlin, pp 840–869 Niaudet P, Boyer O (2016) Idiopathic nephrotic syndrome in children: clinical aspects. In: Avner ED et al (eds) Pediatric Nephrology, 7th edn. Springer-Verlag, Berlin, pp 840–869
4.
Zurück zum Zitat Van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW, Simon A, International HIDS Study Group (2008)Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 87:301–310CrossRef Van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW, Simon A, International HIDS Study Group (2008)Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 87:301–310CrossRef
5.
Zurück zum Zitat Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG, Beckmann JS, van der Meer JW, Delpech M (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 22:178–181CrossRef Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG, Beckmann JS, van der Meer JW, Delpech M (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 22:178–181CrossRef
6.
Zurück zum Zitat Ammouri W, Cuisset L, Rouaghe S, Rolland MO, Delpech M, Grateau G, Ravet N (2007) Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford) 46:1597–1600CrossRef Ammouri W, Cuisset L, Rouaghe S, Rolland MO, Delpech M, Grateau G, Ravet N (2007) Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford) 46:1597–1600CrossRef
7.
Zurück zum Zitat Shendi HM, Walsh D, Edgar JD (2012) Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome. Rheumatol Int 32:249–251CrossRef Shendi HM, Walsh D, Edgar JD (2012) Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome. Rheumatol Int 32:249–251CrossRef
8.
Zurück zum Zitat Klasen IS, Göertz JH, van de Wiel GA, Weemaes CM, van der Meer JW, Drenth JP (2001)Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome. Clin Diagn Lab Immunol 8:58–61PubMedPubMedCentral Klasen IS, Göertz JH, van de Wiel GA, Weemaes CM, van der Meer JW, Drenth JP (2001)Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome. Clin Diagn Lab Immunol 8:58–61PubMedPubMedCentral
9.
Zurück zum Zitat Bader-Meunier B, Florkin B, Sibilia J, Acquaviva C, Hachulla E, Grateau G, Richer O, Farber CM, Fischbach M, Hentgen V, Jego P, Laroche C, Neven B, Lequerré T, Mathian A, Pellier I, Touitou I, Rabier D, Prieur AM, Cuisset L, Quartier P, SOFREMIP (Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie), CRI (Club Rhumatismes et Inflammations) (2011) Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics 128:152–159CrossRef Bader-Meunier B, Florkin B, Sibilia J, Acquaviva C, Hachulla E, Grateau G, Richer O, Farber CM, Fischbach M, Hentgen V, Jego P, Laroche C, Neven B, Lequerré T, Mathian A, Pellier I, Touitou I, Rabier D, Prieur AM, Cuisset L, Quartier P, SOFREMIP (Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie), CRI (Club Rhumatismes et Inflammations) (2011) Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics 128:152–159CrossRef
10.
Zurück zum Zitat Simon A, Drewe E, van der Meer JW, Powell RJ, Kelley RI, Stalenhoef AF, Drenth JP (2004) Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 75:476–483CrossRef Simon A, Drewe E, van der Meer JW, Powell RJ, Kelley RI, Stalenhoef AF, Drenth JP (2004) Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 75:476–483CrossRef
11.
Zurück zum Zitat Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW (2001) Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double- blind, placebo-controlled trial. J Pharmacol Exp Ther 298:1221–1226PubMed Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW (2001) Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double- blind, placebo-controlled trial. J Pharmacol Exp Ther 298:1221–1226PubMed
12.
Zurück zum Zitat Topaloğlu R, Ayaz NA, Waterham HR, Yüce A, Gumruk F, Sanal O (2008) Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up. Clin Rheumatol 27:1317–13120CrossRef Topaloğlu R, Ayaz NA, Waterham HR, Yüce A, Gumruk F, Sanal O (2008) Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up. Clin Rheumatol 27:1317–13120CrossRef
13.
Zurück zum Zitat Simms RW, Prout MN, Cohen AS (1994) The epidemiology of AL and AA amyloidosis. Bailliere’s Clin Rheumatol 8:627–634CrossRef Simms RW, Prout MN, Cohen AS (1994) The epidemiology of AL and AA amyloidosis. Bailliere’s Clin Rheumatol 8:627–634CrossRef
14.
Zurück zum Zitat Picken MM (2007) New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens 16:196–203CrossRef Picken MM (2007) New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens 16:196–203CrossRef
15.
Zurück zum Zitat Drenth JP, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinemia D and periodic fever syndrome: the clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine 73:133–144CrossRef Drenth JP, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinemia D and periodic fever syndrome: the clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine 73:133–144CrossRef
16.
Zurück zum Zitat Simon A, Kremer HP, Wevers RA, Scheffer H, De Jong JG, Van Der Meer JW, Drenth JP (2004) Mevalonate kinase deficiency: evidence for a phenotypic continuum. Neurology 62:994–997CrossRef Simon A, Kremer HP, Wevers RA, Scheffer H, De Jong JG, Van Der Meer JW, Drenth JP (2004) Mevalonate kinase deficiency: evidence for a phenotypic continuum. Neurology 62:994–997CrossRef
17.
Zurück zum Zitat Joroen CH, van der Hilst JC, Frenkel J (2010) Hyperimmunoglobulin D syndrome in childhood. Curr Rheumatol Rep 12:101–107CrossRef Joroen CH, van der Hilst JC, Frenkel J (2010) Hyperimmunoglobulin D syndrome in childhood. Curr Rheumatol Rep 12:101–107CrossRef
19.
Zurück zum Zitat Kostjukovits S, Kalliokoski L, Antila K, Korppi M (2015) Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience. Eur J Pediatr 174:707–714CrossRef Kostjukovits S, Kalliokoski L, Antila K, Korppi M (2015) Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience. Eur J Pediatr 174:707–714CrossRef
21.
Zurück zum Zitat Mulders-Manders CM, Simon A (2015)Hyper-IgDsyndrome/mevalonate kinase deficiency: what is new? Semin Immunopathol 37:371–376 Mulders-Manders CM, Simon A (2015)Hyper-IgDsyndrome/mevalonate kinase deficiency: what is new? Semin Immunopathol 37:371–376
22.
Zurück zum Zitat Siewert R, Ferber J, Horstmann RD, Specker C, Heering PJ, Timmann C (2006) Hereditary periodic fever with systemic amyloidosis: is hyper-IgD syndrome really a benign disease? Am J Kidney Dis 48:41–45CrossRef Siewert R, Ferber J, Horstmann RD, Specker C, Heering PJ, Timmann C (2006) Hereditary periodic fever with systemic amyloidosis: is hyper-IgD syndrome really a benign disease? Am J Kidney Dis 48:41–45CrossRef
Metadaten
Titel
A rare cause of steroid-resistant nephrotic syndrome in a child: Answers
verfasst von
Lale Guliyeva
Yılmaz Tabel
Ali Düzova
Nusret Akpolat
Seza Özen
Rezan Topaloğlu
Betül Sözeri
Publikationsdatum
06.12.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 4/2020
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-019-04385-6

Weitere Artikel der Ausgabe 4/2020

Pediatric Nephrology 4/2020 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.